Regulatory ILC2—Role of IL-10 Producing ILC2 in Asthma
Cells · 2023
DOI: 10.3390/cells12212556 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, 2023. Verfasst von Nahal Emami Fard und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, McMaster University, Hamilton, ON L8N 3Z5, Canada. Hauptthemen laut MEDLINE: Interleukin-10, Asthma. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Over the past two decades, a growing body of evidence observations have shown group two innate lymphoid cells (ILC2) to be critical drivers of Type 2 (T2) inflammatory responses associated with allergic inflammatory conditions such as asthma. ILC2 releases copious amounts of pro-inflammatory T2 cytokines—interleukin (IL)-4, IL-5, IL-9, and IL-13. This review provides a comprehensive overview of the newly discovered regulatory subtype of ILC2 described in murine and human mucosal tissue and blood. These KLRG1+ILC2 have the capacity to produce the anti-inflammatory cytokine IL-10. Papers compiled in this review were based on queries of PubMed and Google Scholar for articles published from 2000 to 2023 using keywords “IL-10” and “ILC2”. Studies with topical relevance to IL-10 production by ILC2 were included. ILC2 responds to microenvironmental cues, including retinoic acid (RA), IL-2, IL-4, IL-10, and IL-33, as well as neuropeptide mediators such as neuromedin-U (NMU), prompting a shift towards IL-10 and away from T2 cytokine production. In contrast, TGF-β attenuates IL-10 production by ILC2. Immune regulation provided by IL-10+ILC2s holds potential significance for the management of T2 inflammatory conditions. The observation of context-specific cues that alter the phenotype of ILC warrants examining characteristics of ILC subsets to determine the extent of plasticity or whether the current classification of ILCs requires refinement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, McMaster University, Hamilton, ON L8N 3Z5, Canada.
ORCID-Profile: Roma Sehmi
Zitieren
APA
Emami Fard, N., Xiao, M., & Sehmi, R. (2023). Regulatory ILC2—Role of IL-10 Producing ILC2 in Asthma. Cells. https://doi.org/10.3390/cells12212556
Vancouver
Emami Fard N, Xiao M, Sehmi R. Regulatory ILC2—Role of IL-10 Producing ILC2 in Asthma. Cells. 2023. doi:10.3390/cells12212556
BibTeX
@article{EmamiFard2023,
author = {Emami Fard, Nahal and Xiao, Maria and Sehmi, Roma},
title = {Regulatory ILC2—Role of IL-10 Producing ILC2 in Asthma},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12212556}
}
EUVIMED